Tissue Regenix Group PLC - ESG Rating & Company Profile powered by AI
The webpage is a free Environmental, Social and Governance analysis for Tissue Regenix Group PLC. The article includes a questions and answers table on Tissue Regenix Group PLC. This ESG rating for Tissue Regenix Group PLC indicates the company's reporting of the UN SDGs.
Tissue Regenix Group PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.8; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.3.
0.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2585 | Samsung Pharm Co Ltd | 0.9 | Low |
| 2585 | Panaxia Labs Israel Ltd | 0.9 | Low |
| 2614 | Tissue Regenix Group PLC | 0.8 | Low |
| 2614 | Genocea Biosciences Inc | 0.8 | Low |
| 2614 | Ilsung Pharmaceutical Co Ltd | 0.8 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tissue Regenix Group PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Tissue Regenix Group PLC report the average age of the workforce?
Sign up for free to unlockDoes Tissue Regenix Group PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Tissue Regenix Group PLC offer flexible work?
Sign up for free to unlockDoes Tissue Regenix Group PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tissue Regenix Group PLC conduct supply chain audits?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tissue Regenix Group PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose water use targets?
Sign up for free to unlockDoes Tissue Regenix Group PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Tissue Regenix Group PLC have a product recall in the last two years?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Tissue Regenix Group PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tissue Regenix Group PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose parental leave metrics?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tissue Regenix Group PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tissue Regenix Group PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tissue Regenix Group PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose its waste policy?
Sign up for free to unlockDoes Tissue Regenix Group PLC report according to TCFD requirements?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose energy use targets?
Sign up for free to unlockDoes Tissue Regenix Group PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tissue Regenix Group PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tissue Regenix Group PLC
These potential risks are based on the size, segment and geographies of the company.
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and GBM-V & Cardiac divisions. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductive to stimulate and regenerate native bone growth. In addition, the company provides DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, Decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it offers OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company provides DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; CardioPure products; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks for ophthalmology and wound covering; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom.